NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Exit Mandelson — leaving questions about Downing Street’s judgment.